Exagen to Present at the Canaccord Genuity 40th Annual Growth Conference
On July 30, 2020, Exagen (Nasdaq: XGN) announced that CEO Ron Rocca will present at the Canaccord Genuity 40th Annual Growth Conference on August 12, 2020, at 2:00 pm EDT. This year's conference will be virtual, and interested individuals can access the webcast through Exagen's investor relations website. Exagen is focused on transforming care for autoimmune disease patients, offering innovative testing products under the AVISE® brand to aid in diagnosis and treatment.
- None.
- None.
SAN DIEGO, July 30, 2020 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), an organization dedicated to transforming the care continuum for patients suffering from autoimmune diseases, today announced that Ron Rocca, President and Chief Executive Officer of Exagen, will present at the Canaccord Genuity 40th Annual Growth Conference on Wednesday, August 12, 2020, at 2:00 pm EDT. The conference will be a virtual event this year.
Interested parties may access a link to the webcast of Mr. Rocca’s presentation online from the investor relations section of the Exagen website at https://investors.exagen.com/. A replay of the webcast will be available using the link for 60 days after the presentation.
About Exagen Inc.
Exagen is dedicated to transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. Exagen has developed and is commercializing a portfolio of innovative testing products under its AVISE® brand, several of which are based on its proprietary Cell-Bound Complement Activation Products, or CB-CAPs, technology. Exagen’s goal is to enable rheumatologists to improve care for patients through the differential diagnosis, prognosis and monitoring of complex autoimmune and autoimmune-related diseases, including SLE and rheumatoid arthritis.
CONTACTS:
Investors
Westwicke Partners
Mike Cavanaugh
Mike.Cavanaugh@westwicke.com
646.677.1838
Company Contact
Exagen Inc.
Kamal Adawi, Chief Financial Officer
KAdawi@exagen.com
760.477.5514
FAQ
When will Exagen CEO Ron Rocca present at the Canaccord Genuity Growth Conference?
How can I access the webcast of Exagen's presentation?
What is the focus of Exagen's business?
What is the ticker symbol for Exagen?
Will there be a replay of the presentation from the conference?
